Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hudecek

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Transplantation|January 22, 2009
Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen usedKristina Bartsch, Haifa Al-Ali, Annette Reinhardt, et al.
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset compositionStanley R Riddell, Daniel Sommermeyer, Carolina Berger, et al.
JMIR Human Factors|January 17, 2024
Trust in and Acceptance of Artificial Intelligence Applications in Medicine: Mixed Methods StudyDaria Shevtsova, Anam Ahmed, Iris W A Boot, et al.
HLA|October 21, 2025
LMP2A-Targeting CAR-T Cells Equipped With Inducible IL-18 to Address EBV-Associated MalignanciesAnna Christina Dragon, Stefanie Thoelke, Philip Mausberg, et al.
Journal for Immunotherapy of Cancer|January 11, 2025
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategiesAnna Fleischer, Sophia Kurth, Johannes Duell, et al.
JCI Insight|August 16, 2019
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor modelsLars Wallstabe, Claudia Göttlich, Lena C Nelke, et al.
Leukemia|February 24, 2018
CAR T-cells targeting FLT3 have potent activity against FLT3<sup>-</sup>ITD<sup>+</sup> AML and act synergistically with the FLT3-inhibitor crenolanibHardikkumar Jetani, Irene Garcia-Cadenas, Thomas Nerreter, et al.
Nature Biotechnology|November 6, 2019
A highly soluble Sleeping Beauty transposase improves control of gene insertionIrma Querques, Andreas Mades, Cecilia Zuliani, et al.
Frontiers in Immunology|August 18, 2025
Direct visualization of chimeric antigen receptors on primary human T cells using <i>d</i>STORM super-resolution microscopyLeon Gehrke, Nicole Seifert, Peter Spieler, et al.
Annals of Hematology|February 12, 2021
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patternsSophia Danhof, Leo Rasche, Anja Mottok, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Transplantation|January 22, 2009
Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen usedKristina Bartsch, Haifa Al-Ali, Annette Reinhardt, et al.
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset compositionStanley R Riddell, Daniel Sommermeyer, Carolina Berger, et al.
JMIR Human Factors|January 17, 2024
Trust in and Acceptance of Artificial Intelligence Applications in Medicine: Mixed Methods StudyDaria Shevtsova, Anam Ahmed, Iris W A Boot, et al.
HLA|October 21, 2025
LMP2A-Targeting CAR-T Cells Equipped With Inducible IL-18 to Address EBV-Associated MalignanciesAnna Christina Dragon, Stefanie Thoelke, Philip Mausberg, et al.
Journal for Immunotherapy of Cancer|January 11, 2025
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategiesAnna Fleischer, Sophia Kurth, Johannes Duell, et al.
JCI Insight|August 16, 2019
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor modelsLars Wallstabe, Claudia Göttlich, Lena C Nelke, et al.
Leukemia|February 24, 2018
CAR T-cells targeting FLT3 have potent activity against FLT3<sup>-</sup>ITD<sup>+</sup> AML and act synergistically with the FLT3-inhibitor crenolanibHardikkumar Jetani, Irene Garcia-Cadenas, Thomas Nerreter, et al.
Nature Biotechnology|November 6, 2019
A highly soluble Sleeping Beauty transposase improves control of gene insertionIrma Querques, Andreas Mades, Cecilia Zuliani, et al.
Frontiers in Immunology|August 18, 2025
Direct visualization of chimeric antigen receptors on primary human T cells using <i>d</i>STORM super-resolution microscopyLeon Gehrke, Nicole Seifert, Peter Spieler, et al.
Annals of Hematology|February 12, 2021
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patternsSophia Danhof, Leo Rasche, Anja Mottok, et al.
Pageof 14